Differentially expressed genes in iron-induced prion protein conversion

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Prion diseases involve the conversion of cellular prion protein (PrP^C) to a protease-resistant form (PrP^res).
• Increased iron levels are observed in prion diseases, linked to the prion protein-ferritin complex.
• Recombinant PrP (rPrP) accumulation and conversion are specifically mediated by Fe(III), not Fe(II).

Purpose of the Study:

• To identify differentially expressed genes in neural cells associated with Fe(III)-induced prion degeneration.
• To investigate the role of iron valence (Fe(III) vs. Fe(II)) in PrP conversion and gene expression changes.
• To explore potential redox mechanisms by which Fe(III) influences PrP folding and disease progression.

Main Methods:

• Utilized Affymetrix microarrays to analyze gene expression profiles in neural cells.
• Treated cells with Fe(III) and Fe(II) to observe differential gene expression patterns.
• Performed functional grouping of identified differentially expressed genes.

Main Results:

• Fe(III) treatment led to significant differential expression of 97 genes (85 upregulated, 12 downregulated) with a ≥1.5-fold change.
• Fe(II) treatment caused only moderate alterations in gene expression, lacking dramatic profile changes.
• Differentially regulated genes were primarily associated with cell growth, maintenance, and transport processes.

Conclusions:

• Fe(III) significantly impacts gene expression in neural cells, suggesting a role in PrP folding and prion disease pathogenesis via redox mechanisms.
• Fe(II) does not induce similar widespread gene expression changes, highlighting the specific role of Fe(III).
• Identification of altered gene expression patterns provides insights into the mechanisms of PrP conversion in neurodegenerative diseases.